iOrganBio
PrivateLast Round
Seed
Oct 29, 2025
Total Funding Raised
$2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
iOrganBio is a biotechnology company that provides an AI-powered platform called CellForge for the intelligent manufacturing of cells and organoids to accelerate disease modeling, regenerative medicine, and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iOrganBio Comparables
Compare iOrganBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ChemT Biotechnology | 86% | |
| Cellino | 81% | |
| BioCurie | 81% |
iOrganBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2025 |
iOrganBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Terasaki Institute for Biomedical Innovation | Seed |
| Alix Ventures | Seed |
| 2ndF | Seed |
| First Star Ventures | Seed |
| IndieBio | Seed |
| Cape Fear BioCapital | Seed |
| SOSV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Jul 17, 2026
Grew 25% QoQ, from 16 to 20 employees.
Recent news
Latest coverage and updates
- hiresJul 23, 2026
iOrganBio, Inc. was planning to hire Lee L. Rubin as Scientific Advisory Board on Jul 23rd '26.
- hiresJul 23, 2026
iOrganBio, Inc. hired Lee L. Rubin as Scientific Advisory Board on Jul 23rd '26.
iOrganBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about iOrganBio's valuation, stock price, and market status.
Is iOrganBio a public or private company?
iOrganBio is a private company.
What is the current stock price of iOrganBio?
iOrganBio is a private company with no public stock price. No recent secondary market data is available.
How much is iOrganBio worth (valuation)?
Valuation information for iOrganBio is not publicly available.
Can I buy iOrganBio stock?
iOrganBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was iOrganBio's last funding round?
iOrganBio's most recent funding round was Seed on October 29, 2025.
Who are the main investors in iOrganBio?
Key investors in iOrganBio include First Star Ventures.
Will iOrganBio IPO soon?
No public IPO plans have been announced for iOrganBio.
How can I track iOrganBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor iOrganBio's secondary market activity and sign up for updates.